-
Signature
-
/s/ Anish Bhatnagar, Attorney-in-Fact
-
Stock symbol
-
SLNO
-
Transactions as of
-
May 26, 2023
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
5/26/2023, 06:39 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
SLNO |
Common Stock |
Award |
$0 |
+29.1K |
+657.29% |
$0.00 |
33.6K |
May 26, 2023 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
SLNO |
Employee stock option (right to buy) |
Award |
$0 |
+87.4K |
|
$0.00 |
87.4K |
May 26, 2023 |
Common Stock |
87.4K |
$5.25 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Officer title: Vice President, Clinical Operations